This company listing is no longer active
CBD Stock Overview
A medicinal cannabis company, engages in the manufacture of cannabis-based ingredients and oral solutions. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Cannasouth Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NZ$0.098 |
| 52 Week High | NZ$0.28 |
| 52 Week Low | NZ$0.096 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 2.08% |
| 1 Year Change | -62.31% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -67.33% |
Recent News & Updates
Shareholder Returns
| CBD | NZ Pharmaceuticals | NZ Market | |
|---|---|---|---|
| 7D | 0% | -7.8% | 1.7% |
| 1Y | -62.3% | -13.3% | 6.7% |
Return vs Industry: CBD underperformed the NZ Pharmaceuticals industry which returned -32.7% over the past year.
Return vs Market: CBD underperformed the NZ Market which returned -5.4% over the past year.
Price Volatility
| CBD volatility | |
|---|---|
| CBD Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.2% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in NZ Market | 8.9% |
| 10% least volatile stocks in NZ Market | 3.0% |
Stable Share Price: CBD has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CBD's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | n/a | www.cannasouth.co.nz |
Cannasouth Limited, a medicinal cannabis company, engages in the manufacture of cannabis-based ingredients and oral solutions. It produces medicinal cannabis products and cannabinoid-based medicines to treat and support the health of patients with certain conditions. It also exports its products.
Cannasouth Limited Fundamentals Summary
| CBD fundamental statistics | |
|---|---|
| Market cap | NZ$32.39m |
| Earnings (TTM) | -NZ$8.81m |
| Revenue (TTM) | NZ$955.55k |
33.9x
P/S Ratio-3.7x
P/E RatioIs CBD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CBD income statement (TTM) | |
|---|---|
| Revenue | NZ$955.55k |
| Cost of Revenue | NZ$2.18m |
| Gross Profit | -NZ$1.22m |
| Other Expenses | NZ$7.59m |
| Earnings | -NZ$8.81m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.027 |
| Gross Margin | -127.65% |
| Net Profit Margin | -921.78% |
| Debt/Equity Ratio | 5.9% |
How did CBD perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/06/22 20:13 |
| End of Day Share Price | 2024/03/25 00:00 |
| Earnings | 2023/12/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cannasouth Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|